These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31787235)

  • 21. Antroquinonol reduces oxidative stress by enhancing the Nrf2 signaling pathway and inhibits inflammation and sclerosis in focal segmental glomerulosclerosis mice.
    Tsai PY; Ka SM; Chao TK; Chang JM; Lin SH; Li CY; Kuo MT; Chen P; Chen A
    Free Radic Biol Med; 2011 Jun; 50(11):1503-16. PubMed ID: 21376112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
    Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
    Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary miR-196a predicts disease progression in patients with chronic kidney disease.
    Zhang C; Liang S; Cheng S; Li W; Wang X; Zheng C; Zeng C; Shi S; Xie L; Zen K; Liu Z
    J Transl Med; 2018 Apr; 16(1):91. PubMed ID: 29636065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum microRNAs levels in primary focal segmental glomerulosclerosis.
    Cai X; Xia Z; Zhang C; Luo Y; Gao Y; Fan Z; Liu M; Zhang Y
    Pediatr Nephrol; 2013 Sep; 28(9):1797-801. PubMed ID: 23463342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrinogen links podocyte injury with Toll-like receptor 4 and is associated with disease activity in FSGS patients.
    Wang H; Zheng C; Xu X; Zhao Y; Lu Y; Liu Z
    Nephrology (Carlton); 2018 May; 23(5):418-429. PubMed ID: 28407405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Focal segmental glomerulosclerosis is induced by microRNA-193a and its downregulation of WT1.
    Gebeshuber CA; Kornauth C; Dong L; Sierig R; Seibler J; Reiss M; Tauber S; Bilban M; Wang S; Kain R; Böhmig GA; Moeller MJ; Gröne HJ; Englert C; Martinez J; Kerjaschki D
    Nat Med; 2013 Apr; 19(4):481-7. PubMed ID: 23502960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS).
    Miao Z; Ertl LS; Newland D; Zhao B; Wang Y; Zang X; Campbell JJ; Liu X; Dang T; Miao S; Krasinski A; Punna S; Zeng Y; McMahon J; Zhang P; Charo IF; Schall TJ; Singh R
    PLoS One; 2018; 13(3):e0192405. PubMed ID: 29561839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
    Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
    J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of TSP-1 and its receptor ITGB3 in the renal tubulointerstitial injury of focal segmental glomerulosclerosis.
    Fan Y; Dong S; Xia Y; Yang X; Lei Q; Xu F; Liang D; Liang S; Zhang M; Yang F; Jing Y; Li L; Zhu X; Bao H; Chen Z; Zeng C
    J Biol Chem; 2024 Aug; 300(8):107516. PubMed ID: 38960036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma microRNA panel is a novel biomarker for focal segmental glomerulosclerosis and associated with podocyte apoptosis.
    Xiao B; Wang LN; Li W; Gong L; Yu T; Zuo QF; Zhao HW; Zou QM
    Cell Death Dis; 2018 May; 9(5):533. PubMed ID: 29748623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of CD8(+) cells in the progression of murine adriamycin nephropathy.
    Wang Y; Wang YP; Tay YC; Harris DC
    Kidney Int; 2001 Mar; 59(3):941-9. PubMed ID: 11231349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
    Kim JS; Han BG; Choi SO; Cha SK
    Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
    Ramezani A; Devaney JM; Cohen S; Wing MR; Scott R; Knoblach S; Singhal R; Howard L; Kopp JB; Raj DS
    Eur J Clin Invest; 2015 Apr; 45(4):394-404. PubMed ID: 25682967
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PDE5 inhibitor, vardenafil, ameliorates progressive pathological changes in a focal segmental glomerulosclerosis mouse model.
    Hu SW; Wang YH; Huang JS; Yang YM; Wu CC; Cheng CW
    Life Sci; 2022 Nov; 309():120992. PubMed ID: 36155178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.
    Kachurina N; Chung CF; Benderoff E; Babayeva S; Bitzan M; Goodyer P; Kitzler T; Matar D; Cybulsky AV; Alachkar N; Torban E
    Am J Physiol Renal Physiol; 2016 May; 310(10):F1148-56. PubMed ID: 26719363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher Urine Exosomal miR-193a Is Associated With a Higher Probability of Primary Focal Segmental Glomerulosclerosis and an Increased Risk of Poor Prognosis Among Children With Nephrotic Syndrome.
    Wang L; Wang J; Wang Z; Zhou J; Zhang Y
    Front Cell Dev Biol; 2021; 9():727370. PubMed ID: 34708038
    [No Abstract]   [Full Text] [Related]  

  • 39. Invariant natural killer T cell agonist modulates experimental focal and segmental glomerulosclerosis.
    Pereira RL; Reis VO; Semedo P; Buscariollo BN; Donizetti-Oliveira C; Cenedeze MA; Soares MF; Pacheco-Silva A; Savage PB; Câmara NO; Keller AC
    PLoS One; 2012; 7(3):e32454. PubMed ID: 22427838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic basis of adult-onset nephrotic syndrome and focal segmental glomerulosclerosis.
    Liu J; Wang W
    Front Med; 2017 Sep; 11(3):333-339. PubMed ID: 28776307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.